Get E&O weekly. | Subscribe | Digital health research from Brian Dolan.
Welcome to E&O.
Last week's newsletter had a 60 percent open rate. Here's what's happening this week:
- More on this below, but the Proteus lay-offs are top of mind. There's a lot of digital health talent looking for jobs in 2020. Here's hoping they all land on their feet.
- EtectRx secured FDA 510(k) clearance for its smart pill, ingestible event marker, medication adherence technology. The small company is a challenger to Proteus Digital Health, which developed a similar technology and received FDA de novo clearance back in 2012.
- Happify Health published an interesting study in JMIR that showed a brief HRVB (heart rate variability biofeedback) training session on a smartphone reduced levels of salivary alpha-amylase following a stressful experience. The study used Happify's app, Breather.